Pfizer shares owned by Vantage Consulting Group
Quarter-by-quarter ownership of Pfizer (PFE) shares owned by Vantage Consulting Group
from 13F filings
Historical chart of Vantage Consulting Group investment in Pfizer
Tip: Access up to 7 years of quarterly data
All positions including Pfizer held by Vantage Consulting Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Pfizer by Vantage Consulting Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $237k | 8.5k | 27.98 |
| 2024-03-31 | $242k | 8.7k | 27.75 |
| 2023-12-31 | $234k | 8.1k | 28.79 |
| 2023-09-30 | $224k | 6.8k | 33.17 |
| 2023-06-30 | $217k | 5.9k | 36.68 |
| 2023-03-31 | $248k | 6.1k | 40.80 |
| 2022-12-31 | $239k | 4.7k | 51.24 |
| 2022-09-30 | $235k | 5.4k | 43.77 |
| 2022-06-30 | $252k | 4.8k | 52.36 |
| 2022-03-31 | $236k | 4.6k | 51.66 |
| 2021-12-31 | $291k | 4.9k | 59.10 |
| 2021-09-30 | $230k | 5.3k | 43.01 |
| 2021-06-30 | $221k | 5.6k | 39.24 |
| 2020-12-31 | $65k | 1.8k | 36.70 |